Development of an inactivated vaccine candidate for SARS-CoV-2

Gao, Qiang, Bao, Linlin, Mao, Haiyan, Wang, Lin, Xu, Kangwei, Yang, Minnan, Li, Yajing, Zhu, Ling, Wang, Nan, Lv, Zhe, Gao, Hong, Ge, Xiaoqin, Kan, Biao, Hu, Yaling, Liu, Jiangning, Cai, Fang, Jiang, Deyu, Yin, Yanhui, Qin, Chengfeng, Li, Jing, Gong, Xuejie, Lou, Xiuyu, Shi, Wen, Wu, Dongdong, Zhang, Hengming, Zhu, Lang, Deng, Wei, Li, Yurong, Lu, Jinxing, Li, Changgui, Wang, Xiangxi, Yin, Weidong, Zhang, Yanjun, Qin, Chuan·2020·Science
DOI 10.1126/science.abc1932

Cited by (1,435)

Items 901–1,000 of 1,435

  1. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes
    Cristina dos Santos Ferreira, Yasmmin Martins, Rangel Celso Souza, Ana Tereza Ribeiro de Vasconcelos · 2021 · PeerJ
  2. miRNAs in SARS-CoV-2 Infection: An Update
    Asim Azhar, Wajihul Hasan Khan, Khaled A. Alhosaini, Mohammad Amjad Kamal · 2022 · Current Drug Metabolism
  3. Neutralization Heterogeneity of Circulating SARS-CoV-2 Variants to Sera Elicited by a Vaccinee or Convalescent
    Meng Zhang, Yixin Gong, Shunchang Jiao · 2022 · Future Virology
  4. Animal Models for COVID-19 Therapeutic Development: Where We Are and Where We Need to Go
    Sihai Zhao, Jianglin Fan, Enqi Liu · 2022 · Frontiers in Microbiology
  5. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
    Agustín Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Rafaela González‐Montelongo, Julia Alcoba-Flórez, Rodrigo Trujillo‐González, Diego García-Martínez de Artola, Helena Gil-Campesino et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  6. The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice
    Kangwei Xu, Jing Li, Lu Xu, Xiaoqin Ge, Kaiqin Wang, Jiahao Wang, Zhizhong Qiao, Yaru Quan, Changgui Li · 2024 · Vaccines
  7. Coronavirus disease-19 vaccine development utilizing promising technology
    Yihan Wang, Man Xing, Dongming Zhou · 2020 · Current Opinion in HIV and AIDS
  8. Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2
    Xiang Ling Meng, Qiuyue Lou, Wen-ying Yang, Ran Chen, Wen-hua Xu, Yang Yang, Lei Zhang, Tao Xu, Huifen Xiang · 2020 · European Journal of Pharmacology
  9. Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review
    Masarra M. Sakr, Noha Salah Elsayed, Ghadir S. El-Housseiny · 2021 · Microbial Pathogenesis
  10. COVID-19, des vaccins à la vitesse de l’éclair
    Yanis Feraoun, Pauline Maisonnasse, Roger Le Grand, Anne‐Sophie Beignon · 2021 · médecine/sciences
  11. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
    Xiangchuan He, Longfei Ding, Kangli Cao, Haoran Peng, Chenjian Gu, Yutang Li, Duoduo Li, Lanlan Dong, Xiujing Hong, Xiangwei Wang et al. · 2021 · Emerging Microbes & Infections
  12. Assessment of the Field Utility of a Rapid Point-of-Care Test for SARS-CoV-2 Antibodies in a Household Cohort
    Mehal Churiwal, Kelly Lin, Salman Khan, Srijana Chhetri, Meredith Muller, Kathleen Tompkins, J. W. G. Smith, Christy Litel, Maureen Whittelsey, C. Andrew Basham et al. · 2021 · American Journal of Tropical Medicine and Hygiene
  13. Identification of four linear B-cell epitopes on the SARS-CoV-2 spike protein able to elicit neutralizing antibodies
    Lin Li, Zhongpeng Zhao, Xiaolan Yang, Wendong Li, Shaolong Chen, Ting Sun, Lu Wang, Yufei He, Guang Liu, Xiaohan Han et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Broad-spectrum affinity chromatography of SARS-CoV-2 and Omicron vaccines from ligand screening to purification
    Jing Ma, Xiaoyan Dong, Yan Ping Sun, Qinghong Shi · 2025 · Journal of Chromatography A
  15. One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test
    Yeşim Tok, Rabia Can Sarınoğlu, Seyhan Ördekçi, Şerife Yılmaz, Güneş Sözmen Özçolpan, Ayşen Bayram, Okan Kadir Nohut, İpek Koçer, Ufuk Over Hasdemir, Mert Ahmet Kuşkucu et al. · 2023 · Vaccines
  16. Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers
    Nataniel Tandirogang, Evi Fitriany, Nursaci Mardania, Miftahul Jannah, Bilqis Faiqotun Nabilah Dilan, Sapta Rahayuning Ratri, Arfian Deny Prakoso, Meiliati Aminyoto, Yuliana Kartika Ningrum, Ika Fikriah et al. · 2023 · Molecular and Cellular Biomedical Sciences
  17. Development of a universal real-time RT-PCR assay for detection of pan-SARS-coronaviruses with an RNA-based internal control
    Beibei Yu, Changping Xu, Shiwang Huang, Jun Ni, Jiancang Zhou, Yuting Zhang, Maomao Wu, Jun Zhang, Lei Fang · 2023 · Frontiers in Microbiology
  18. Sequence of COVID-19 Vaccination and COVID-19 Infection and Their Association With the Development of Active Tuberculosis: A Case-Control Study
    Satiti Palupi, Imran Pambudi, Asik Surya · 2023 · Cureus
  19. Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants
    Jing Ma, Yongdong Huang, Guodong Jia, Xiaoyan Dong, Qinghong Shi, Yan Ping Sun · 2024 · International Journal of Biological Macromolecules
  20. Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates
    Alexandra Detrille, Steve Huvelle, Marit J. van Gils, Tatiana Geara, Quentin Pascal, Jonne L. Snitselaar, Laëtitia Bossevot, Mariangela Cavarelli, Nathalie Dereuddre‐Bosquet, Francis Relouzat et al. · 2025 · Nature Communications
  21. Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development
    Chiranjib Chakraborty, Yi-Hao Lo, Manojit Bhattacharya, Arpita Das, Zhi‐Hong Wen · 2025 · Molecular Therapy — Nucleic Acids
  22. COVID and Animal Trials: A Systematic Review
    Muhamood Moothedath, Muhaseena Muhamood, Yadnit S. Bhosale, Aseem Bhatia, Pranav Gupta, Medapati Rama Haranadha Reddy, Rahul Tiwari · 2021 · Journal of Pharmacy And Bioallied Sciences
  23. COVID-19 Vaccination: The Mainspring of Challenges and the Seed of Remonstrance
    Hoda Najjar, Hadeel T. Al-Jighefee, Abeer Qush, Muna Nizar Ahmed, Sara Awwad, Layla Kamareddine · 2021 · Vaccines
  24. Will Peptides Help to Stop COVID-19?
    Viktoriya G. Krut’, Sergei A. Chuvpilo, Irina V. Astrakhantseva, Liubov I. Kozlovskaya, Grigory Aleksandrovich Efimov, Andrey Kruglov, Marina S. Drutskaya, Sergei A. Nedospasov · 2022 · Biochemistry (Moscow)
  25. The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling
    Mo’tasem M. Alsmadi · 2022 · Drug Metabolism and Personalized Therapy
  26. Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study
    Rongdong Huang, Xiaoqin Liu, Fangqin Xie · 2022 · Diabetes Therapy
  27. Review on COVID-19 Vaccines
    Liyana Majid, Sengamalam Radhakrishnan, Ramachandran Vignesh, Ravindran Muthukumarasamy · 2022 · Research Journal of Pharmacy and Technology
  28. Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
    Uraporn Phumisantiphong, Sirichan Chunhakan, Anan Manomaipiboon, Jakravoot Maneerit, Pornchai Dechanuwong, Thananda Trakarnvanich, Wadakorn Oajaum, Wilawan Chan-in · 2023 · Vaccine X
  29. SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations
    Xiaohan Zhang, Mansheng Li, Nana Zhang, Yunhui Li, Fei Teng, Yongzhe Li, Xiaomei Zhang, Xingming Xu, Haolong Li, Yunping Zhu et al. · 2024 · Advanced Science
  30. Failla Memorial Lecture: The Many Facets of Heavy-Ion Science
    Marco Durante · 2021 · Radiation Research
  31. Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
    Jaewoo Hong, Hyunjhung Jhun, Yeo-Ok Choi, Afeisha S. Taitt, Suyoung Bae, Young-Min Lee, Chang‐Seon Song, Su Cheong Yeom, Soohyun Kim · 2021 · Immune Network
  32. An overview of preclinical animal models for SARS-CoV-2 pathogenicity
    Itti Munshi, Aditya Khandvilkar, Shrinivas Chavan, G. Sachdeva, S. Mahale, U. Chaudhari · 2021 · The Indian journal of medical research
  33. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
    Hui Yin Lim, Masita Arip, Abdul Aziz Al-Fattah Bin Yahaya, Seyed Davoud Jazayeri, Sibrandes Poppema, Chit Laa Poh · 2021 · Frontiers in Bioscience-Landmark
  34. Pre-clinical models to define correlates of protection for SARS-CoV-2
    Caolann Brady, Tom Tipton, Stéphanie Longet, Miles W. Carroll · 2023 · Frontiers in Immunology
  35. Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
    Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle N. Barra, Rodrigo Puentes, Loredana Arata, Jonnathan Grossolli, Boris Riveros-Rodriguez, Luis Ardiles, Julio Santelises, Valeria Vásquez-Sáez et al. · 2023 · Frontiers in Public Health
  36. Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
    Ying Chen, Caiqin Hu, Zheng Wang, Junwei Su, Shuo Wang, Bin Li, Xiang Liu, Zhenzhen Yuan, Dan Li, Hong Wang et al. · 2023 · Pathogens
  37. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
    Salman Sadullah Usmani, Gajendra P. S. Raghava · 2020 · Frontiers in Immunology
  38. A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool
    German I. Todorov, Vladimir Nikolaevich Uversky · 2020 · Biomolecules
  39. Promising Immunotherapies against COVID‐19
    Haodong Guo, Lili Zhou, Zhenyu Ma, Zhixin Tian, Fangfang Zhou · 2021 · Advanced Therapeutics
  40. Update: Drug treatment options for coronavirus disease 2019 (COVID-19)
    Yueming Shao, Jun Chen, Hongzhou Lu · 2021 · BioScience Trends
  41. Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical Models
    Min-Wen Ku, M. Bourgine, Pierre Authié, Jodie Lopez, K. Nemirov, Fanny Moncoq, Amandine Noirat, B. Vesin, Fabien Névo, C. Blanc et al. · 2020 · bioRxiv
  42. The peripheral T cell population is associated with pneumonia severity in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus 2
    Noriyo Nagata, Naoko Iwata‐Yoshikawa, Kaori Sano, Akira Ainai, Nozomi Shiwa, Masayuki Shirakura, Noriko Kishida, Tomoko Arita, Yasushi A. Suzuki, Toshihiko Harada et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  43. A modified porous silicon microparticle promotes mucosal delivery of SARS-CoV-2 antigen and induction of potent and durable systemic and mucosal T helper 1 skewed protective immunity
    Awadalkareem Adam, Qing Shi, Binbin Wang, Jing Zou, Junhua Mai, Samantha R. Osman, Wenzhe Wu, Xuping Xie, Patricia V. Aguilar, Xiaoyong Bao et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Omicron Reactive Multi Protein Specific CD4 T Cells Defines Cellular Immune Response Induced by Inactivated Virus Vaccines
    Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran et al. · 2022 · SSRN Electronic Journal
  45. Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
    Huijie Yang, Ying Xie, Shuaiyao Lu, Yufang Sun, Kaiqin Wang, Shuyan Li, Junzhi Wang, Guoyang Liao, Changgui Li · 2023 · Vaccines
  46. Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
    Weitong Yao, Yujun Li, Danting Ma, Xu-Dong Hou, Haimin Wang, Xiaojuan Tang, Dechun Cheng, He Zhang, Chengzhi Du, Hong Pan et al. · 2023 · Microbiology Spectrum
  47. Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines
    Jeswin Joseph, Kandan Sethumadhavan, Priyanca Ahlawat, Malavika Prakash, Gayatri Kandpal, Gowtham Raj, Harshal Srivastava, Packirisamy Charulekha, Aswin K Dev, Akshaya Radhakrishnan et al. · 2025 · ACS Nano
  48. Vacunas SARS CoV-2, estudios en fase III
    Carolina Ibáñez Guelfenbein, Juan Pablo Torres, María Elena Santolaya de Pablo · 2021 · Revista chilena de infectología
  49. Coronavirus (COVID-19) vaccines
    Mario Blekić, Blaženka Kljaić Bukvić · 2021 · Liječnički vjesnik
  50. Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
    Ileanet Avalos, Thailin Lao, Elsa Rodríguez Rodríguez, Yasser Zamora, Alianet Rodríguez, Ailyn C. Ramòn, Gilda Lemos, Ania Cabrales, Mónica Béquet‐Romero, Dionne Casillas et al. · 2022 · Vaccines
  51. The effects of inactivated SARS‐CoV ‐2 vaccination and subsequent infection of pregnant mice on the behaviors of offspring
    Kaili Lin, Meixuan Liu, Lu Sun · 2022 · Animal Models and Experimental Medicine
  52. Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice
    Zhuo-xin Li, Sheng Feng, He Zhang et al. · 2022 · Archives of Virology
  53. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
  54. Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development
    Lilan Xie, Yaoming Li · 2022 · Vaccine
  55. Cross-Reactive Profile Against Two Conserved Coronavirus Antigens in Sera from SARS-CoV-2 Hybrid and Vaccinated Immune Donors
    Yadira Lobaina, Rong Chen, Panchao Ai, Li-Ling Yang, Liz Alvarez‐Lajonchere, Edith Suzarte, Changyuan Tan, Ricardo Silva, Zaixue Jiang, Ke Yang et al. · 2023 · Viral Immunology
  56. Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
    Ece Tavukçuoğlu, Hamdullah Yanık, Mubaida Parveen, Sıla Ulutürk, Mine Durusu Tanrıöver, Ahmet Çağkan İnkaya, Murat Akova, Serhat Ünal, Güneş Esendağlı · 2023 · Scientific Reports
  57. Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
    Melyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin · 2023 · Vaccines
  58. Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
    Xiaomeng He, Yingyin Cao, Yanmei Lu, Furong Qi, Haiyan Wang, Xuejiao Liao, Gang Xu, Biao Yang, Junhua Ma, Dapeng Li et al. · 2023 · Frontiers in Immunology
  59. In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG
    Xun Wang, Minghui Li, Panpan Lu, Chen Li, Chaoyue Zhao, Xiaoyu Zhao, Rui Qiao, Yuchen Cui, Yanjia Chen, Jiayan Li et al. · 2023 · Pathogens
  60. Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic
    Rabeea Siddique, Qian Bai, Muhammad Adnan Shereen, Ghulam Nabi, Guang Han, Farooq Rashid, Saeed Ahmed, Aigerim Benzhanova, Mengzhou Xue, Suliman Khan · 2020 · Human Vaccines & Immunotherapeutics
  61. COVID‑19 in China: From epidemiology to treatment (Review)
    Hongtao Chen, Shipin Wu, Xiaoyong Zhang · 2020 · Experimental and Therapeutic Medicine
  62. Vaksin SARS-CoV-2: Tinjauan Kepustakaan
    Dominicus Husada · 2020 · Journal Of The Indonesian Medical Association
  63. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies
    Muhammad Hassan, Muhammad Zalkifal, Abdul Wahab, Samia Afzal, Shazia Rafique, Muhammad Shahid, Mohsin Ahmad Khan, Nadeem Ahmed, Muhammad Idrees, Ahmad Ali Shahıd · 2021 · Critical Reviews in Eukaryotic Gene Expression
  64. The Immune Response to SARS-CoV-2: Mechanisms, Aging, Sequelae, and Vaccines
    Marcelo A. Alarcón, Carolina Espinoza · 2022 · Mini-Reviews in Medicinal Chemistry
  65. Development, analysis, and preclinical evaluation of inactivated vaccine candidate for prevention of Covid-19 disease
    Engin Alp Onen, Kıvılcım Sönmez, Funda Yıldırım, Elif Demirci, Aydın Gürel · 2022 · All Life
  66. In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine
    Seyedeh Zeinab Masoomi Nomandan, Maryam Azimzadeh Irani, Seyed Masoud Hosseini · 2022 · Frontiers in Molecular Biosciences
  67. An Expert System Dataset for Checking the Potential for Administering a Covid-19 Vaccine in Indonesia: Forward-Chaining Inference Machine Approach
    Rosyid Ridlo Al Hakim, Glagah E. Setyowisnu, Agung Pangestu · 2022 · Journal of Global Engineering Research and Science
  68. Characterization and analysis of linear epitopes corresponding to SARS‐CoV‐2 outbreak in Jilin Province, China
    Wenying Gao, Zhaolong Li, Qingtian Guan, Wenzhe Cui, Baishong Zheng, Qiang Ding, Guoyue Lv, Jiancheng Xu, Wenyan Zhang · 2022 · Journal of Medical Virology
  69. Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine
    Kentaro Muranishi, Mao Kinoshita, Keita Inoue, Junya Ohara, Toshihito Mihara, Kazuki Sudo, Ken J. Ishii, Teiji Sawa, Hiroyasu Ishikura · 2023 · Vaccines
  70. Willingness of the General Public to Receive the COVID-19 Vaccine During a Second-Level Alert — Beijing Municipality, China, May 2020
    Rui Ma, Luodan Suo, Li Lu · 2021 · China CDC Weekly
  71. An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development
    Liang Zhang, Shuaiyin Chen, Weiguo Zhang, Haiyan Yang, Yuefei Jin, Guangcai Duan · 2021 · Frontiers in Microbiology
  72. Assessing humoral immune response after two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workers
    Hadiye Demirbakan, İpek Koçer, M. Erdoğan, Ayşen Bayram · 2022 · Public Health
  73. A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection
    Ahmed O. Hassan, Natasha M. Kafai, I. Dmitriev, J. Fox, Brittany K. Smith, Ian B. Harvey, Rita E. Chen, Emma S. Winkler, Alex W. Wessel, J. Case et al. · 2020 · bioRxiv
  74. Adopting STING agonist cyclic dinucleotides as a potential adjuvant for SARS-CoV-2 vaccine
    Jun Wu, Yong‐Xiang Chen, Yanmei Li · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible
    Jorge Enrique Gómez‐Marín, Jhon Carlos Castaño Osório, Manuel A. Patarroyo · 2020 · Infectio
  76. No evidence for human monocyte-derived macrophage infection and antibody-mediated enhancement of SARS-CoV-2 infection
    Obdulio García-Nicolás, Philip V’kovski, Ferdinand Zettl, Gert Zimmer, Volker Thiel, Artur Summerfield · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets
    Magen Ellen Francis, Brian Richardson, Mara McNeil, Melissa L. Rioux, Mary K. Foley, Anni Ge, Roger D. Pechous, Jason Kindrachuk, Cheryl Cameron, Christopher Richardson et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through multiple mechanisms
    Pan Liu, Can Yue, Bo Meng, Tianhe Xiao, Sijie Yang, Shuo Liu, Fanchong Jian, Qianhui Zhu, Yuanling Yu, Yan-Yan Ren et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Life Engineering of Materials: Artificial Materials as Plugins for Biological Regulations
    Jiake Lin, Lishan Hu, Xiaoyu Wang, Ruikang Tang · 2025 · Advanced Materials
  80. Antiviral Inactivated Vaccines: Looking to the Past to Face the Future—A Narrative Review
    Francisca Hildemagna Guedes-da-Silva, Victor A. R. Pereira, Sara Torres, María Pilar García García, Kelvinson Fernandes Viana, Jerson Lima Silva, Andréa Cheble Oliveira, Andre M. O. Gomes · 2025 · Vaccines
  81. Vaccination and COVID-19: impact on long-COVID
    Gustavo N. Guimarães, N. S. Brunetti, D. G. de Lima, J. L. Proença-Módena, Alessandro S. Farias · 2025 · Frontiers in Immunology
  82. Rapid production of COVID-19 subunit vaccine candidates and their immunogenicity evaluation in pigs
    Renhe Yan, Jun Liu, Zedian Chen, Pengfei Wan, Tiekun Liang, Kanhe Li, Dandan Liu, Manxin Ma, Xueji Chen, Andrew Li et al. · 2024 · International Journal of Biological Macromolecules
  83. An overview of SARS-CoV-2 viral proteins with relevance to improved diagnostic and therapeutic platforms
    Christopher W. Chung, Pratiba Irudayaraj, Emran O. Lallow, Ziyang Xu, Young K. Park, Sagar B. Kudchodkar, Luis J. Montaner, Alagarsamy Srinivasan, Kar Muthumani · 2024 · Frontiers in Virology
  84. A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity
    Yuhan Li, Xianwen Zhang, Wanbo Tai, Xinyu Zhuang, Huicheng Shi, Shumin Liao, Xinyang Yu, Rui Mei, Xingzhao Chen, Yanhong Huang et al. · 2024 · EBioMedicine
  85. Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
    Dipa Rani Roy, Md. Mosfequr Rahman, Arnaba Saha Chaity, Md Abu Reza, Ariful Haque · 2022 · Scientific Reports
  86. ChAdOx1 nCoV-19, BNT162b2 and CoronaVac Vaccines Do Not Induce as Strong Neutralising Antibodies with Broad Variant Protection as Infection and Suggest Vaccines that Induce Broader Sterilising Immunity are Essential to Stop the Pandemic
    Jia Xin Chua, Lindy Gillian Durrant, Yin Ling Chok, Oi Ming Lai · 2022 · iScience
  87. Desenvolvimento de Vacinas: o potencial do Instituto Butantan na Pandemia de Covid-19
    Gabriela Simões Pazelli, Ana Marisa Chudzinski‐Tavassi, Alexandre Guimarães Vasconcellos · 2022 · Cadernos de Prospecção
  88. The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients
    Ting Wang, Yang Bai, Lele Bai · 2023 · Medicine
  89. Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay
    Changping Xu, Zhengyang Wang, Beibei Yu, Zhenhuang Pan, Jun Ni, Yan Feng, Shiwang Huang, Maomao Wu, Jiancang Zhou, Lei Fang et al. · 2024 · Virus Research
  90. Triple Inhibition of SARS‐CoV‐2 by Rhenium(I) Acetylacetonato Tricarbonyl Phosphine Complexes: Structural Features, DFT Calculations, HS Analysis and In Silico Molecular Docking Study
    Amanda-Lee Ezra Manicum, Amani Direm, Hamza Athmani · 2024 · ChemistrySelect
  91. Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges
    Idris Nasir Abdullahi, Anthony Uchenna Emeribe, Hafeez Aderinsayo Adekola, Sharafudeen Dahiru Abubakar, Amos Dangana, Halima Ali Shuwa, Sunday Theophilus Nwoba, Jelili Olaide Mustapha, Muyideen Haruna, Adepeju Kafayat Olowookere et al. · 2020 · Human Vaccines & Immunotherapeutics
  92. An Immunological Outlook on SARS Coronavirus (SARS-CoV-2) and Its Current Clinical Status
    Jyoti Prakash Sahoo, Upasana Mohapatra, Sushree Suparna Mahapatra · 2020 · Journal of Pharmaceutical Research International
  93. COVID-19 X-ray Image Diagnostic with Deep Neural Networks
    Gabriel Gomes de Oliveira, Rafael Padilha, André Dorte, Luis Cereda, Luiz Miyazaki, Maurício Lopes, Zanoni Dias · 2020 · Lecture notes in computer science
  94. A REVIEW ON THE FIFTH PANDEMIC: CORONAVIRUS
    Navdeep Kaur, KAUR SIMRANPREET, KAUR MANJINDER · 2020 · Asian Journal of Pharmaceutical and Clinical Research
  95. Safety and immunogenicity evaluation of inactivated whole-virus-SARS-COV-2 as emerging vaccine development in Egypt
    Amani Ali Saleh, Mohamed Ahmed Saad, Islam Ryan, Magdy Amin, Mohamed I Shindy, Wael A. Hassan, Mahmoud Samir, Ayman A Khattab, Sherein Saied. Abdelgayed, Mohamed Gomaa Seadawy et al. · 2021 · Antibody Therapeutics
  96. Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response
    Qiong Long, Ying Li Yang, Mengli Yang, Hongmei Bai, Wenjia Sun, Xu Yang, Weiwei Huang, Duo Li, Yanbing Ma · 2022 · Nanomedicine Nanotechnology Biology and Medicine
  97. Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?
    Kwang Poo Chang, Joseph Michael Reynolds, Ying Liu, Johnny J. He · 2022 · Vaccines
  98. Genetic variants of COVID-19 and vaccination. Is there a Correlation?
    Nagwa A. Sabri, Raslan Mohamed Ahmed, Shehata Eslam Mansour, Raslan Sara Ahmed · 2022 · Open Journal of Proteomics and Genomics
  99. Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
    Jianhua Li, Xiaoyan Li, Erqiang Wang, Jin-ye Yang, Jiaxuan Li, Chen Huang, Yanjun Zhang, Keda Chen · 2022 · Vaccines
  100. Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
    Haoting Zhan, Li Yang, Yongmei Liu et al. · 2023 · Journal of Infection